Britz-McKibbin awarded by Cystic Fibrosis Canada
Philip Britz-McKibbin has been awarded a 3-year, $100,000 per year grant from Cystic Fibrosis Canada for his program entitled “Metabolomics for Improved Screening and Prognosis of Cystic Fibrosis Infants: Translation of New Biomarkers for Resolving Diagnostic Dilemmas”. Congratulations to Phil and his team for this expansion of their exciting work in this area.
Uncategorized
Related News
News Listing
![Image of Vassili Kanellis](https://chemistry.mcmaster.ca/app/uploads/2024/04/vassili-e1713486674605.jpg)
April 17, 2024
![Photo of Professor Gary J. Schrobilgen in front of a period table of elements display](https://chemistry.mcmaster.ca/app/uploads/2024/04/Gary_J_Schrobilgen_Photo_2024.png)
La Fondation de la Maison de la Chimie ➚
Prof. Schrobilgen Awarded 2024 International Henri Moissan Prize
Uncategorized
April 1, 2024
![John Valliant with Fusion Pharmaceuticals banner](https://chemistry.mcmaster.ca/app/uploads/2023/05/Fusion.png)
McMaster Daily News ➚
AstraZeneca moves to acquire Dr. Valliant founded Fusion Pharmaceuticals for $2.4 billion (US)
Uncategorized
March 21, 2024